Try our Advanced Search for more refined results

October 25, 2018

Walgreen CO et al v. Novartis Pharmaceuticals Corporation et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 15, 2019

    Actavis Dooms Exforge Buyers' Pay-For-Delay Claims

    Buyers of the hypertension medication Exforge will have to pursue their pay-for-delay allegations against the drug's brand maker Novartis and generics company Par Pharmaceutical under a harder-to-prove legal standard, thanks to the U.S. Supreme Court's Actavis decision, a New York federal judge held Thursday.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!